Skip to main content

Translating molecular insight into better therapies for brain tumor patients.

The Youngblood Lab at Northwestern University Feinberg School of Medicine studies the molecular mechanisms that drive brain tumor growth, aggressiveness and treatment resistance. By integrating genomic, epigenetic and immune approaches, we work to uncover new insights into how these tumors form and evolve and to translate those discoveries into better therapies for patients facing some of the most challenging central nervous system tumors. Our work spans discovery science and translational application, from defining the epigenetic drivers of tumor behavior to developing novel immunotherapeutic and treatment strategies for tumors that resist surgery.

Join Our Team

We are committed to rigorous, reproducible science and to validating our findings and sharing our data openly so the field can move forward together. Above all, we are dedicated to training the next generation of physician-scientists and researchers, fostering a supportive, collaborative and intellectually rigorous environment where scientists at every stage can grow, develop and do their best work.

Meet Our Team Contact Us

Group photo of the Youngblood Lab team

News & Recent Events

Feinberg AOSC Pser Sessin – 11.06.2026

Feinberg AOSC Poster Session – 11.06.2026

Ella Foster, an M2 student from our lab presented her poster, “Evaluating the Mechanistic Dependence of IACS-8803 on STING Signaling in Meningioma,” at Feinberg’s annual Area of Scholarly Concentration (AOSC) Poster Session where second-year medical students present their research to faculty and peers. Ella’s poster won 2nd place and she received the AOSC Visionary Poster Prize.

Spaial-ATAC-Hi-C Paper Pblished – 09.01.2026

Spatial-ATAC-Hi-C Paper Published – 09.01.2026

In collaboration with the Yue Lab, our new study introducing Spatial-ATAC-Hi-C has been published in Nature Methods. The technology maps 3D genome organization and chromatin accessibility together directly on tissue slides, while keeping the tissue’s spatial layout intact.

Meningima Hislgy and Mleclar Tesing Wrkflw Paper Pblished – 10.01.2026

Meningioma Histology and Molecular Testing Workflow Paper Published – 10.01.2026

Our study led by MSTP candidate Harrsha Congivaram, in collaboration with Dr. Craig Horbinski, has been published in Neuro-Oncology. The work proposes an evidence-based workflow for which meningiomas should get molecular testing.